AIHealthcare Analytics

Knowledge Wiki

Wiki › Artificial Intelligence for Therapeutic Peptide Discovery and Development

Artificial Intelligence for Therapeutic Peptide Discovery and Development

OVERVIEW
Rev 1 Oct 29, 2026 04:12 UTC 1 sources

Therapeutic peptides combine biological specificity with chemical versatility, and AI now contributes to their identification, design, and optimization across receptor agonists, antagonists, and other major peptide classes. However, peptide discovery cannot be reduced to generating amino-acid sequences: therapeutic performance also depends on chemistry, conformation, assay context, stability, delivery, safety, manufacturability, and in vivo exposure. This critical review examines AI use across the peptide development pipeline, emphasizing that generative models must be integrated with physicochemical validation, manufacturing feasibility assessment, and clinical translation pathways. The gap between sequence generation and therapeutic efficacy remains substantial, requiring human expertise in chemistry, pharmacology, and translational medicine to guide AI-assisted discovery. ---

Sources: harvested
🔒

Subscribe to read full wiki analysis

Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.

View Plans & Subscribe

New users get a 7-day trial — no credit card required.

← Back to Wiki Index